A clinical trial, however, found no benefit from routine use. These results, published in Scientific Reports, support a trial of cannabidiol (CBD), a non-psychoactive compound, active in the body, for neuropathic
A clinical trial, however, found no benefit from routine use. These results, published in Scientific Reports, support a trial of cannabidiol (CBD), a non-psychoactive compound, active in the body, for neuropathic